Trends in Antibiotic Resistance Patterns and Burden of Escherichia Coli Infections in Young Children: A Retrospective Cross-Sectional Study in Shenzhen, China from 2014–2018
Sandip Patil,Hongyu Chen,Yunsheng Chen,Shaowei Dong,Huirong Mai,Bruno Silvester Lopes,Sixi Liu,Feiqiu Wen
DOI: https://doi.org/10.2147/IDR.S425728
2023-08-22
Infection and Drug Resistance
Abstract:Sandip Patil, 1, 2 Hongyu Chen, 3 Yunsheng Chen, 3 Shaowei Dong, 2 Huirong Mai, 1 Bruno Silvester Lopes, 4, 5 Sixi Liu, 1 Feiqiu Wen 1, 2 1 Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China; 2 Paediatric Research Institute, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China; 3 Department of Laboratory Medicine, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China; 4 School of Health and Life Sciences, Teesside University, Middlesbrough, UK; 5 National Horizons Centre, Teesside University, Darlington, UK Correspondence: Feiqiu Wen; Sixi Liu, Department of Haematology and Oncology, Shenzhen Children's Hospital, 7019 Yitian Road, Futian District, Shenzhen, Guangdong Province, People's Republic of China, Tel +86-755-83009888, Email ; Purpose: The emergence of multi-drug resistant ESBL-producing E. coli poses a global health problem. In this study, we aimed to investigate the prevalence of E. coli infections and their antibiotic susceptibility profiles in paediatric clinical cases in Shenzhen, China from Jan 1, 2014, to Jan 30, 2019, while also determining temporal trends, identifying ESBL-producing strains, and recommending potential empirical antibiotic therapy options. Methods: We isolated a total of 4148 E. coli from different specimens from a single paediatric healthcare centre. Additionally, we obtained relevant demographic data from the hospital's electronic health records. Subsequently, we performed antimicrobial susceptibility testing for 8 classes of antibiotics and assessed ESBL production. Results: Out of the 4148 isolates, 2645 were from males. The highest burden of E. coli was observed in the age group of 0– 1 years, which gradually declined over the five-year study period. Antimicrobial susceptibility results indicated that 82% of E. coli isolates were highly resistant to ampicillin, followed by 52.36% resistant to cefazolin and 47.46% resistant to trimethoprim/sulfamethoxazole. Notably, a high prevalence of ESBL production (49.54%) was observed among the E. coli isolates, with 60% of them displaying a multi-drug resistance phenotype. However, it is worth mentioning that a majority of the isolates remained susceptible to ertapenem and imipenem. Our findings also highlighted a decrease in E. coli infections in Shenzhen, primarily among hospitalized patients in the 0– 1 year age group. However, this decline was accompanied by a considerably high rate of ESBL production and increasing resistance to multiple antibiotics. Conclusion: Our study underscores the urgent need for effective strategies to combat multi-drug resistant ESBL-producing E. coli Infections. Keywords: E. coli infections, antibiotic susceptibilities, young children, MDR Escherichia coli , a gram-negative pathogen in the Enterobacteriaceae family, is a significant cause of bloodstream, urinary tract, gastrointestinal, and respiratory infections worldwide. 1 The global incidence of E. coli infections is increasing, according to the Global Burden of Foodborne Diseases report. Approximately 111 million illnesses and 63,000 deaths are attributed to diarrheagenic E. coli annually worldwide, Infection rates vary across different regions. 2 This substantial burden necessitates a comprehensive understanding of the pathogen's impact and its growing antimicrobial resistance crisis. This alarming burden highlights the urgent need for effective strategies to tackle E. coli infections and their associated challenges. Notably, the impact of E. coli on bloodstream infections, while not as clear as its role in urinary tract infections, has been identified as a leading cause of bloodstream infections. 3 E. coli infections impose a substantial burden on pediatric health, affecting various body sites and warranting a comprehensive understanding of their prevalence and implications for effective disease management. 4 E. coli bloodstream infections were not widely recognized as a common issue at the beginning of the 20th century; however, it has been consistently rising worldwide over the decades as shown by numerous studies. 5,6 The gut microbiome is a common source of extraintestinal infections caused by E. coli and its population varies among individuals of different ages and lifestyles. 7 The emergence of E. coli is a critical issue in the -Abstract Truncated-
pharmacology & pharmacy,infectious diseases